Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1 | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, facioscapulohumeral muscular dystrophy, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease	Enrolling by invitation	Phase 1 / Phase 2	2026-10-05		NCT06131983

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sarepta Therapeutics, Inc.	15

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alfred Health	Melbourne	Australia	32
Centre For Human Drug Research	Leiden	Netherlands	3
Centro Clinico Nemo Milann	Milan	Italy	1
Fondazione Policlinico Universitario A. Gemelli	Roma	Italy	4
Hospital Universitari l Politecnic La Fe de Valencia	Valencia	Spain	1
Hospital Universitario Ramon y Cajal	Madrid	Spain	141
Hospital Universitario Vall D'Hebron	Barcelona	Spain	86
Liverpool Hospital	Liverpool	Australia	66
McGill University	Montreal	Canada	2
Neurologische Universitätsklinik Am Rku	Ulm	Germany	1
New Zealand Clinical Research	Auckland	New Zealand	4
Sunshine Coast University Hospital	Birtinya	Australia	34
University of Alberta	Edmonton	Canada	3
University of Calgary	Calgary	Canada	3
Universitätsklinikum München	München	Germany	1
Wesley Research Institute	Auchenflower	Australia	1